Literature DB >> 15205579

Renal cell carcinoma: etiology, incidence and epidemiology.

Masaru Murai1, Mototsugu Oya.   

Abstract

PURPOSE OF REVIEW: The incidence of renal cell carcinoma has been increasing worldwide. Although the etiology of renal cell carcinoma is largely unknown, recent epidemiological investigations have shed some light on the issue. This article reviews the literature related to etiology, incidence and epidemiology of renal cell carcinoma published between May 1, 2003 and April 30, 2004. RECENT
FINDINGS: Accumulating evidence has confirmed the increasing incidence of renal cell carcinoma. A racial disparity has been reported for the first time. Being overweight and obesity were confirmed to be risk factors for renal cell carcinoma. Recreational exercise was shown to reduce the risk, whereas a Western-style diet and smoking increased the risk. Occupational exposure may relate to the development of renal cell carcinoma; however, no definite carcinogens have so far been identified. A susceptibility to develop renal cell carcinoma may also exist in relation to the gene polymorphisms of detoxifying enzymes including glutathione S-transferase and cytochrome P450.
SUMMARY: Although high-risk groups for renal cell carcinoma have been identified, a large portion of renal cell carcinoma still has an unknown etiology. Life-style modifications might reduce renal cell carcinoma risks. Further studies are thus needed to explore the etiology of renal cell carcinoma in terms of gene-environment interactions.

Entities:  

Mesh:

Year:  2004        PMID: 15205579     DOI: 10.1097/01.mou.0000135078.04721.f5

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  49 in total

1.  Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.

Authors:  Yang Su; Jingxiao Lu; Xianguo Chen; Chaozhao Liang; Pengcheng Luo; Cong Qin; Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-03       Impact factor: 4.553

2.  Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.

Authors:  Juanjuan Wu; Yushan Zhang; Nicole Frilot; Jae I Kim; Wan-Ju Kim; Yehia Daaka
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  Unusual gastric and pancreatic metastatic renal cell carcinoma presentation 10 years after surgery and immunotherapy: A case report and a review of literature.

Authors:  Chiara Riviello; Ilaria Tanini; Greta Cipriani; Pietro Pantaleo; Carlo Nozzoli; Alberto Poma; Viligiardi Riccardo; Andrea Valeri
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 4.  IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.

Authors:  Alexandra Kirner; Andrea Mayer-Mokler; Carsten Reinhardt
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  4-Pyridylanilinothiazoles that selectively target von Hippel-Lindau deficient renal cell carcinoma cells by inducing autophagic cell death.

Authors:  Michael P Hay; Sandra Turcotte; Jack U Flanagan; Muriel Bonnet; Denise A Chan; Patrick D Sutphin; Phuong Nguyen; Amato J Giaccia; William A Denny
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

6.  Expression of endothelin 2 and localized clear cell renal cell carcinoma.

Authors:  Brian M Bot; Jeanette E Eckel-Passow; Shauna N LeGrand; Tracy Hilton; John C Cheville; Todd Igel; Alexander S Parker
Journal:  Hum Pathol       Date:  2011-11-01       Impact factor: 3.466

7.  Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.

Authors:  Solène-Florence Kammerer-Jacquet; Sarah Medane; Karim Bensalah; Jean-Christophe Bernhard; Mokrane Yacoub; Frantz Dupuis; Alain Ravaud; Grégory Verhoest; Romain Mathieu; Benoit Peyronnet; Angélique Brunot; Brigitte Laguerre; Alexandra Lespagnol; Jean Mosser; Frédéric Dugay; Marc-Antoine Belaud-Rotureau; Nathalie Rioux-Leclercq
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

8.  Renal cell carcinoma and arterial hypertension.

Authors:  Milan Stojanovic; Branislav Goldner; Dusan Ivkovic
Journal:  Clin Exp Nephrol       Date:  2009-01-29       Impact factor: 2.801

9.  Differences in presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience.

Authors:  Dionisios Mitropoulos; Andreas Petrolekas; Ioannis Anastasiou; Ioannis Adamakis; Aspasia Kyroudi-Voulgari; Efraim Serafetinides; Anastasios Zervas
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-27       Impact factor: 4.553

10.  No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma.

Authors:  Monica Bertoia; Demetrius Albanes; Susan T Mayne; Satu Männistö; Jarmo Virtamo; Margaret E Wright
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.